|
Quotes & Info
|
| OGXI > SEC Filings for OGXI > Form 8-K on 3-May-2012 | All Recent SEC Filings |
3-May-2012
Results of Operations and Financial Condition, Financial Statemen
On May 3, 2012, OncoGenex Pharmaceuticals, Inc. (the "Company") issued a press release announcing its financial results for the first quarter of 2012. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
(d) Exhibits
Exhibit No. Description
99.1 Press release of OncoGenex Pharmaceuticals, Inc. dated May 3, 2012
The information in Item 2.02 of this Form 8-K and Exhibit 99.1 attached hereto is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
|
|